Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 9096 | HLA (HLA) | connective tissue disease | NA | NA | NA | positive | |
| because hla genes appear to be linked to immune response genes, these data suggest that such genes may exist in patients with this form of cutaneous necrotizing venulitis with associated connective tissue disease. | |||||||
| 310679 | HLA (HLA) | connective tissue disease | NA | NA | NA | unclassified | |
| this report emphasizes the association between inflammatory connective tissue disease and a specific hla type within a single kindred. | |||||||
| 1370621 | NA (NA) | connective tissue disease | NA | NA | NA | unclassified | |
| molecular genetic analysis of hla-dr and hla-dq genes among anti-u1-70-kd autoantibody positive connective tissue disease patients. | |||||||
| 1370621 | HLA-DR (HLA-DR) | connective tissue disease | NA | NA | NA | unclassified | |
| molecular genetic analysis of hla-dr and hla-dq genes among anti-u1-70-kd autoantibody positive connective tissue disease patients. | |||||||
| 1370621 | HLA-DRB1 (HLA-DRB1) | connective tissue disease | NA | NA | NA | unclassified | |
| a common cluster of shared amino acids, or a shared epitope, identified within hla-drb1 among anti-u1-70-kd autoantibody positive connective tissue disease patients may be important in regulating an autoimmune response to the u1-70-kd antigen. | |||||||
| 1370621 | HLA-DRB1*04 | polyp | NA | NA | NA | positive | |
| we have recently found that the presence of autoantibodies against the 70-kd polypeptide of u1 rnp (u1-70-kd) is associated with hla-dr4 and dr2. | |||||||
| 1370621 | HLA-DR2 (BROAD ANTIGEN) | polyp | NA | NA | NA | positive | |
| we have recently found that the presence of autoantibodies against the 70-kd polypeptide of u1 rnp (u1-70-kd) is associated with hla-dr4 and dr2. | |||||||
| 1398730 | HLA-DR3 (BROAD ANTIGEN) | connective tissue disease | NA | dexamethasone | NA | positive | |
| pregnant women at high risk with known connective tissue disease, previous children with congenital heart block, high titers of ss-a-/ss-b-antibodies and immunogenetic predisposition (hla-dr3) have to be monitored intensively because of the possibility of a prophylaxis with dexamethasone and, in some selected cases, plasmapheresis. | |||||||
| 1398730 | HLA-DR3 (BROAD ANTIGEN) | heart block | NA | dexamethasone | NA | positive | |
| pregnant women at high risk with known connective tissue disease, previous children with congenital heart block, high titers of ss-a-/ss-b-antibodies and immunogenetic predisposition (hla-dr3) have to be monitored intensively because of the possibility of a prophylaxis with dexamethasone and, in some selected cases, plasmapheresis. | |||||||
| 2140681 | HLA-DRB1*04 | connective tissue disease | NA | NA | NA | unclassified | |
| human autoantibodies against the 70-kd polypeptide of u1 small nuclear rnp are associated with hla-dr4 among connective tissue disease patients. | |||||||
Copyright 2024